Detalles de la búsqueda
1.
Comparative evaluation of a laboratory-developed real-time PCR assay and RealStar® Adenovirus PCR Kit for quantitative detection of human adenovirus.
Virol J
; 15(1): 149, 2018 09 27.
Artículo
en Inglés
| MEDLINE | ID: mdl-30261891
2.
Tenofovir alafenamide versus tenofovir disoproxil fumarate, coformulated with elvitegravir, cobicistat, and emtricitabine, for initial treatment of HIV-1 infection: two randomised, double-blind, phase 3, non-inferiority trials.
Lancet
; 385(9987): 2606-15, 2015 Jun 27.
Artículo
en Inglés
| MEDLINE | ID: mdl-25890673
3.
Week 144 resistance analysis of elvitegravir/cobicistat/emtricitabine/tenofovir DF versus atazanavir+ritonavir+emtricitabine/tenofovir DF in antiretroviral-naïve patients.
HIV Clin Trials
; 15(5): 218-30, 2014.
Artículo
en Inglés
| MEDLINE | ID: mdl-25350960
4.
Cobicistat versus ritonavir as a pharmacoenhancer of atazanavir plus emtricitabine/tenofovir disoproxil fumarate in treatment-naive HIV type 1-infected patients: week 48 results.
J Infect Dis
; 208(1): 32-9, 2013 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-23532097
5.
Co-formulated elvitegravir, cobicistat, emtricitabine, and tenofovir disoproxil fumarate versus ritonavir-boosted atazanavir plus co-formulated emtricitabine and tenofovir disoproxil fumarate for initial treatment of HIV-1 infection: a randomised, double-blind, phase 3, non-inferiority trial.
Lancet
; 379(9835): 2429-2438, 2012 Jun 30.
Artículo
en Inglés
| MEDLINE | ID: mdl-22748590
6.
Co-formulated elvitegravir, cobicistat, emtricitabine, and tenofovir versus co-formulated efavirenz, emtricitabine, and tenofovir for initial treatment of HIV-1 infection: a randomised, double-blind, phase 3 trial, analysis of results after 48 weeks.
Lancet
; 379(9835): 2439-2448, 2012 Jun 30.
Artículo
en Inglés
| MEDLINE | ID: mdl-22748591
7.
Efficacy and safety 48 weeks after switching from efavirenz to rilpivirine using emtricitabine/tenofovir disoproxil fumarate-based single-tablet regimens.
HIV Clin Trials
; 14(5): 216-23, 2013.
Artículo
en Inglés
| MEDLINE | ID: mdl-24144898
8.
Tenofovir alafenamide fumarate.
Antivir Ther
; 27(2): 13596535211067600, 2022 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-35499175
9.
Activity of elvitegravir, a once-daily integrase inhibitor, against resistant HIV Type 1: results of a phase 2, randomized, controlled, dose-ranging clinical trial.
J Infect Dis
; 201(6): 814-22, 2010 Mar 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-20146631
10.
Comparative performance of two commercial sample-to-result systems for hepatitis C virus quantitation and genotyping.
Expert Rev Mol Diagn
; 20(12): 1253-1258, 2020 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-32893699
11.
Tenofovir DF, emtricitabine, and efavirenz vs. zidovudine, lamivudine, and efavirenz for HIV.
N Engl J Med
; 354(3): 251-60, 2006 Jan 19.
Artículo
en Inglés
| MEDLINE | ID: mdl-16421366
12.
Evaluation of RealStar® Alpha Herpesvirus PCR Kit for Detection of HSV-1, HSV-2, and VZV in Clinical Specimens.
Biomed Res Int
; 2019: 5715180, 2019.
Artículo
en Inglés
| MEDLINE | ID: mdl-31687393
13.
The safety and efficacy of tenofovir DF in combination with lamivudine and efavirenz through 6 years in antiretroviral-naïve HIV-1-infected patients.
HIV Clin Trials
; 8(3): 164-72, 2007.
Artículo
en Inglés
| MEDLINE | ID: mdl-17621463
14.
The safety and efficacy of switching stavudine to tenofovir df in combination with lamivudine and efavirenz in hiv-1-infected patients: three-year follow-up after switching therapy.
HIV Clin Trials
; 8(6): 381-90, 2007.
Artículo
en Inglés
| MEDLINE | ID: mdl-18042503
15.
Comparative evaluation of a laboratory developed real-time PCR assay and the RealStar® HHV-6 PCR Kit for quantitative detection of human herpesvirus 6.
J Virol Methods
; 246: 112-116, 2017 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-28476346
16.
Evaluation of the HIV lipodystrophy case definition in a placebo-controlled, 144-week study in antiretroviral-naive adults.
Antivir Ther
; 11(2): 179-86, 2006.
Artículo
en Inglés
| MEDLINE | ID: mdl-16640099
17.
Efficacy and safety of tenofovir alafenamide versus tenofovir disoproxil fumarate given as fixed-dose combinations containing emtricitabine as backbones for treatment of HIV-1 infection in virologically suppressed adults: a randomised, double-blind, active-controlled phase 3 trial.
Lancet HIV
; 3(4): e158-65, 2016 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-27036991
18.
Switching from tenofovir disoproxil fumarate to tenofovir alafenamide in antiretroviral regimens for virologically suppressed adults with HIV-1 infection: a randomised, active-controlled, multicentre, open-label, phase 3, non-inferiority study.
Lancet Infect Dis
; 16(1): 43-52, 2016 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-26538525
19.
Drug-drug and drug-food interactions between tenofovir disoproxil fumarate and didanosine.
J Clin Pharmacol
; 45(12): 1360-7, 2005 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-16291710
20.
Systemic and renal pharmacokinetics of adefovir and tenofovir upon coadministration.
J Clin Pharmacol
; 45(8): 935-40, 2005 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-16027404